Amlodipine + Valsartan
Avasart Plus tablets contain two active substances: amlodipine and valsartan. Both substances help control high blood pressure.
Both active substances inhibit the constriction of blood vessels. As a result, blood vessels dilate, and blood pressure decreases. Avasart Plus is used to treat high blood pressure in adults who are not adequately controlled by amlodipine or valsartan alone.
Before taking Avasart Plus, discuss with your doctor if:
Your doctor may recommend regular monitoring of kidney function, blood pressure, and electrolyte levels (e.g., potassium) in your blood. See also section "When not to take Avasart Plus".
Avasart Plus is not recommended for children and adolescents (under 18 years of age).
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take. Your doctor may need to adjust your dose and/or take other precautions. In some cases, it may be necessary to stop taking one of the medicines. This is especially true for certain medicines, such as:
Do not eat grapefruits or drink grapefruit juice while taking Avasart Plus, as they may increase the levels of one of the active substances - amlodipine - in your blood. This may lead to unpredictable and increased blood pressure-lowering effects of Avasart Plus.
Pregnancy
Tell your doctor if you are pregnant, think you may be pregnant, or are planning to become pregnant. Your doctor will normally advise you to stop taking Avasart Plus before you become pregnant or as soon as you know you are pregnant, and will advise you to take a different medicine instead of Avasart Plus. Do not take Avasart Plus during the first 3 months of pregnancy, and do not take it after the 3rd month of pregnancy, as it may seriously harm your baby.
Breastfeeding
Tell your doctor if you are breastfeeding or plan to breastfeed. It is not recommended to take Avasart Plus while breastfeeding - your doctor may prescribe a different medicine if you want to breastfeed, especially if you are breastfeeding a newborn or premature baby.
Amlodipine passes into breast milk in small amounts.
Before taking any medicine, consult your doctor or pharmacist.
This medicine may cause dizziness, which may affect your ability to concentrate. Do not drive, operate machinery, or perform tasks that require attention until you know how Avasart Plus affects you.
This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which is essentially sodium-free.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor.
This will help you get the best results from your treatment and reduce the risk of side effects.
The usual dose of Avasart Plus is one tablet per day.
Depending on your response to treatment, your doctor may increase or decrease the dose of Avasart Plus.
Do not take more than the recommended dose.
Your doctor will exercise caution when increasing the dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
If you have taken too many Avasart Plus tablets or if someone else has taken your tablets, contact your doctor immediately.
If you forget to take a dose, take it as soon as you remember. Then take the next tablet at the usual time. However, if it is almost time for your next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.
Stopping treatment with Avasart Plus may worsen your condition. Do not stop taking your medicine without consulting your doctor.
Like all medicines, Avasart Plus can cause side effects, although not everybody gets them.
Such serious side effects have been reported in a small number of patients (rare - may affect up to 1 in 1,000 people).
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Amlodipine
The following side effects have been reported. If any of them are troublesome or persist for more than a week, consult your doctor.
Common (may affect up to 1 in 10 people):
central nervous system dizziness, drowsiness, palpitations (feeling of heartbeat), sudden reddening, especially of the face, swelling of the ankles (edema), abdominal pain, nausea.
mood changes, anxiety, depression, insomnia, tremors, taste disturbances, fainting, lack of sensation, vision disturbances, impaired vision, ringing in the ears, low blood pressure, sneezing/runny nose due to nasal inflammation (rhinitis), indigestion, vomiting, hair loss, excessive sweating, itching, skin discoloration, urinary disturbances, increased need to urinate at night, frequent urination, impotence, breast discomfort or enlargement in men, pain, general feeling of being unwell, muscle pain, muscle cramps.
confusion.
reduced white blood cell count, reduced platelet count, which may lead to unusual bruising or bleeding, increased blood sugar levels (hyperglycemia), gum swelling, abdominal bloating (gastritis), liver function disorders, liver inflammation, yellowing of the skin (jaundice), increased liver enzyme activity, as shown in some diagnostic tests, increased muscle tension, blood vessel inflammation, often with skin rash, hypersensitivity to light, disorders including stiffness, tremors, and/or difficulty moving.
Valsartan
Frequency not known (cannot be estimated from the available data):
reduced red blood cell count, fever, sore throat or mouth ulcers due to infection, spontaneous bleeding or bruising, high potassium levels in the blood, abnormal liver function test results, worsening of kidney function and severe kidney function disorders, swelling, mainly of the face and throat, muscle pain, rash, purple spots, fever, itching, allergic reaction, blistering of the skin (a condition called bullous pemphigoid).
If you experience any of these symptoms, contact your doctor immediately.
Reporting side effects
If you experience any side effects, including those not listed in this leaflet, please tell your doctor or pharmacist, or nurse. Side effects can be reported directly to
Department for Monitoring of Adverse Reactions to Medicinal Products
Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: 22 49-21-301, fax: 22 49-21-309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Do not store above 30°C.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP:". The expiry date refers to the last day of that month.
Do not use this medicine if you notice that the packaging is damaged.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Avasart Plus, 5 mg + 80 mg (8 mm in diameter), are round, biconvex, yellow film-coated tablets with "I" on one side and "LD" on the other.
Avasart Plus, 5 mg + 160 mg (13.5 mm x 7 mm), are oval, biconvex, yellow film-coated tablets with "2" on one side and "LD" on the other.
Avasart Plus, 10 mg + 160 mg (13.5 mm x 7 mm), are oval, biconvex, white film-coated tablets with "3" on one side and "LD" on the other.
Avasart Plus is available in packs containing 28, 30, 56, 60, 90, 98, or 280 tablets.
Not all pack sizes may be marketed.
Polfarmex S.A.
ul. Józefów 9
99-300 Kutno
Poland (Poland)
Tel.: 24 357 44 44
Fax: 24 357 45 45
e-mail: polfarmex@polfarmex.pl
Balkanpharma Dupnitza AD
3 Samokovsko Shosse Str.
Dupnitza 2600,
Bulgaria
More detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.